Targeted drug conjugate systems for ovarian cancer chemotherapy
Ovarian cancer is a highly lethal disease that affects women. Early diagnosis and treatment of women with early-stage disease improve the probability of survival. Unfortunately, the majority of women with ovarian cancer are diagnosed at advanced stages 3 and 4 which makes treatment challenging. Whil...
Main Authors: | Omotola D. Ogundipe, Oluwabukunmi Olajubutu, Simeon K. Adesina |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-09-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332223009423 |
Similar Items
-
Drug Delivery Strategies for the Treatment of Pancreatic Cancer
by: Oluwabukunmi Olajubutu, et al.
Published: (2023-04-01) -
Improved targeting of an anti‐TAG‐72 antibody drug conjugate for the treatment of ovarian cancer
by: Megan Minnix, et al.
Published: (2020-07-01) -
Drug Combination in Cancer Treatment—From Cocktails to Conjugated Combinations
by: Yosi Gilad, et al.
Published: (2021-02-01) -
Antibody-drug conjugates: the paradigm shifts in the targeted cancer therapy
by: Devesh Aggarwal, et al.
Published: (2023-08-01) -
Progress and Future Directions with Peptide-Drug Conjugates for Targeted Cancer Therapy
by: Jakob Lindberg, et al.
Published: (2021-10-01)